Biogen Inc. (ETR:IDP)
Germany · Delayed Price · Currency is EUR 109.15
-2.90 (-2.59%)
Jul 16, 2025, 5:35 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Multiple Sclerosis | 4.35B | Log In | Log In | Log In | Log In | Upgrade |
Multiple Sclerosis Growth | -8.36% | Log In | Log In | Log In | Log In | Upgrade |
Other | 2.46B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 7.73% | Log In | Log In | Log In | Log In | Upgrade |
Rare Disease | 1.99B | Log In | Log In | Log In | Log In | Upgrade |
Rare Disease Growth | 19.28% | Log In | Log In | Log In | Log In | Upgrade |
Biosimilars | 793.10M | Log In | Log In | Log In | Log In | Upgrade |
Biosimilars Growth | 0.32% | Log In | Log In | Log In | Log In | Upgrade |
Alzheimer's Disease | - | Log In | Log In | Log In | Log In | Upgrade |
Other Product | 82.50M | Log In | Log In | Log In | Log In | Upgrade |
Other Product Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 2.46B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 7.73% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | 2.46B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 4.88% | Log In | Log In | Log In | Log In | Upgrade |
United States | 3.24B | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | 1.85% | Log In | Log In | Log In | Log In | Upgrade |
International | 3.98B | Log In | Log In | Log In | Log In | Upgrade |
International Growth | -0.65% | Log In | Log In | Log In | Log In | Upgrade |
Other | 2.46B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 4.88% | Log In | Log In | Log In | Log In | Upgrade |